BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuen JWY, Kim DD, Procyshyn RM, Panenka WJ, Honer WG, Barr AM. A Focused Review of the Metabolic Side-Effects of Clozapine. Front Endocrinol (Lausanne). 2021;12:609240. [PMID: 33716966 DOI: 10.3389/fendo.2021.609240] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Meyerowitz-katz G, Bramwell S, Jayaballa R, Assur Y, Vasani D, Ganapathy R, Maberly G, Brakoulias V. Evaluating the Effectiveness of Joint Specialist Case Conferences in Improving Diabetes Control in Patients With Schizophrenia on Clozapine. J Nerv Ment Dis 2022;Publish Ahead of Print. [DOI: 10.1097/nmd.0000000000001590] [Reference Citation Analysis]
2 García Cano AM, Jiménez Mendiguchía L, Rosillo Coronado M, Gómez Lozano A, del Rey-mejías ÁL, Fresco Merino M, Marchán Pinedo M, Araujo-castro M. Causes of hyperprolactinaemia in the primary care setting: How to optimise hyperprolactinaemia management. Endocrinología, Diabetes y Nutrición 2022. [DOI: 10.1016/j.endinu.2022.01.011] [Reference Citation Analysis]
3 Wildridge B, Rozewicz S, Mohamed A, James J, Connolly G. Use of clozapine for psychosis and chorea in Huntington's disease systematic narrative review. Prog Neurol Psychiatry 2022;26:38-43. [DOI: 10.1002/pnp.750] [Reference Citation Analysis]
4 Boyda HN, Pham M, Huang J, Ho AA, Procyshyn RM, Yuen JWY, Honer WG, Barr AM. Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance. Front Pharmacol 2022;13:765905. [PMID: 35242029 DOI: 10.3389/fphar.2022.765905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bergonzi MC, Bilia AR, Landucci E. Applications of innovative technologies to the delivery of antipsychotics. Drug Discov Today 2021:S1359-6446(21)00426-8. [PMID: 34601123 DOI: 10.1016/j.drudis.2021.09.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Taub S, Krivoy A, Whiskey E, Shergill SS. New approaches to antipsychotic medication adherence - safety, tolerability and acceptability. Expert Opin Drug Saf 2021;:1-8. [PMID: 34541978 DOI: 10.1080/14740338.2021.1983540] [Reference Citation Analysis]
7 Greabu M, Badoiu SC, Stanescu-Spinu II, Miricescu D, Totan AR, Badoiu SE, Costagliola M, Jinga V. Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review. Int J Mol Sci 2021;22:9782. [PMID: 34575946 DOI: 10.3390/ijms22189782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Molden E. Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies. Expert Opin Drug Metab Toxicol 2021;17:1211-21. [PMID: 34461790 DOI: 10.1080/17425255.2021.1974400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Chakrabarti S. Clozapine resistant schizophrenia: Newer avenues of management. World J Psychiatr 2021; 11(8): 429-448 [PMID: 34513606 DOI: 10.5498/wjp.v11.i8.429] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
10 Gammon D, Cheng C, Volkovinskaia A, Baker GB, Dursun SM. Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders? Biomolecules 2021;11:1030. [PMID: 34356654 DOI: 10.3390/biom11071030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
11 Lian L, Kim DD, Procyshyn RM, Fredrikson DH, Cázares D, Honer WG, Barr AM. Efficacy of long-acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta-analysis. Early Interv Psychiatry 2021. [PMID: 34263540 DOI: 10.1111/eip.13202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Chang GR, Liu HY, Yang WC, Wang CM, Wu CF, Lin JW, Lin WL, Wang YC, Lin TC, Liao HJ, Hou PH, Chan CH, Lin CF. Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Int J Mol Sci 2021;22:6680. [PMID: 34206460 DOI: 10.3390/ijms22136680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Yuen JWY, Wu C, Wang CK, Kim DD, Procyshyn RM, Panenka WG, Honer WG, Barr AM. A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance. Psychoneuroendocrinology 2021;129:105257. [PMID: 34023734 DOI: 10.1016/j.psyneuen.2021.105257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]